Synapse Open Synapse
Patents & IP

"Shotgun approach" to functional claiming fatal to RNA editing claims in Australia

IP Kat · · 4 min read

The Australian Patent Office (APO) has issued a decision finding that ProQR Therapeutics II B.V.'s RNA editing antisense oligonucleotide claims are invalid for lack of sufficiency and support due to broad functional limitations and "unbridled" medical use claims in Wrays Solutions Pty Ltd v ProQR Therapeutics II B.V.

Latest from IP Kat